|
Recent Newsletters
FDA approves empagliflozin for HFpEF | CDC's new guidance on vaccine-related myocarditis | Recurrent MR after TEER |
Breaking News: FDA approves empagliflozin for HFpEF |
A potential new treatment for MIS-C | Eating vegetables does little to prevent CVD | Amyloidosis & TAVR |
Vascular & Endovascular: Directional atherectomy systems recalled | When heart attack patients need PCI |
AstraZeneca COVID vaccine increases blood clot risk | Abbott's latest FDA approval | On-pump vs. off-pump CABG |
Interventional & Surgery: Heart Team consultations lead to better patient outcomes | New data on left main PCI |
4 medications & technologies that could transform cardiology in 2022 | Electrophysiologists debut new tech |